Symposium on immunosuppressive drugs. Late effects of immunosuppressive anticancer drugs.

No abstract is available for this paper.

• Publication year

  1967

• Venue

  Federation proceedings

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 5337286
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CHLORNAPHAZINE AS A BLADDER CARCINOGEN.

  2009cited by this paper
• Symposium on immunosuppressive drugs. Effect of cancer chemotherapeutic agents on normal tissues in man.

  1967cited by this paper
• The role of vincristine in the treatment of childhood acute leukemia

  1966cited by this paper
• Hepatotoxic effects of methotrexate

  1966cited by this paper
• Methotrexate induced hepatitis in childhood leukemia.

  1965cited by this paper
• Mercaptopurine and acquired tubular dysfunction in adult nephrosis.

  1965cited by this paper
• The effect of busulfan on human epithelia.

  1965cited by this paper
• FURTHER OBSERVATIONS ON LATE SOMATIC EFFECTS OF RADIOMIMETIC CHEMICALS AND X-RAYS IN MICE.

  1965cited by this paper
• Problems and pitfalls in the evaluation of anticancer drugs

  1965cited by this paper
• Cytologic dysplasia occurring after busulfan (Myleran) therapy. A syndrome resembling adrenocortical insufficiency and atrophic bronchitis.

  1965cited by this paper
• DRUGS AS TERATOGENS IN ANIMALS AND MAN.

  1965cited by this paper
• CONGENITAL ANOMALIES PROBABLY INDUCED BY CYCLOPHOSPHAMIDE.

  1964cited by this paper
• CHLORNAPHAZIN (ERYSAN) MAY INDUCE CANCER OF THE URINARY BLADDER.

  1964cited by this paper
• BREAST CANCER AND CYTOLOGIC DYSPLASIA IN MANY ORGANS AFTER BUSULFAN (MYLERAN).

  1964cited by this paper
• METHOTREXATE-INDUCED HEPATIC INJURY IN AN ADULT. A CASE REPORT.

  1964cited by this paper
• HEPATOTOXICITY OF MERCAPTOPURINE.

  1964cited by this paper
• Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man

  1964cited by this paper
• LONG TERM RESULTS ACHIEVED WITH THE USE OF ALKYLATING AGENTS IN MALIGNANT LYMPHOMA AND HODGKIN'S DISEASE.

  1964cited by this paper
• POSSIBLE TERATOGENIC EFFECT OF CHLORAMBUCIL ON A HUMAN FETUS.

  1963cited by this paper
• Cytologic Dysplasia Related to Busulfan (Myleran) Therapy Report of a Case

  1963cited by this paper
• Liver damage after chemotherapy for leukemia and lymphoma.

  1962cited by this paper
• Studies related to the mechanisms of action of cytotoxic alkylating agents: a review.

  1962cited by this paper
• Cyclophosphamide in the treatment of common neoplastic diseases of childhood.

  1962cited by this paper
• Interstitial pulmonary fibrosis following busulfan therapy.

  1961cited by this paper
• A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy.

  1961cited by this paper
• Role of Cytotoxic Agents in Production of Amyloidosis in Hodgkin's Disease

  1961cited by this paper
• Hepatic fibrosis in children with acute leukemia. A complication of therapy

  1960cited by this paper
• Urethane-induced hepatic failure in man.

  1960cited by this paper
• Effects of cancer chemotherapeutic agents on the human fetus.

  1960cited by this paper
• CLINICAL EXPERIENCES WITH ACTINOMYCINS D, KS2, AND F1 (KS4) *

  1960cited by this paper
• Transplacental transmission of busulfan (myleran) in a mother with leukemia. Production of fetal malformation and cytomegaly.

  1960cited by this paper
• Toxic complications of treatment with 6-mercaptopurine; two cases with hepatic necrosis and intestinal ulceration.

  1960cited by this paper
• Hepatitis in association with prolonged 6-mercaptopurine therapy.

  1959cited by this paper
• Comparative study of 6-chloropurine and 6-mercaptopurine in acute leukemia in adults.

  1959cited by this paper
• THE COMPARATIVE EFFECTS OF FIVE POLYFUNCTIONAL ALKYLATING AGENTS ON THE RAT FETUS, WITH ADDITIONAL NOTES ON THE CHICK EMBRYO

  1958cited by this paper
• MYLERAN THERAPY IN BRONCHOGENIC CARCINOMA

  1958cited by this paper
• CARCINOGENIC ACTION OF ALKYLATING AGENTS

  1958cited by this paper
• MYLERAN IN THE TREATMENT OF LYMPHOMAS

  1958cited by this paper
• Epithelial atypias with chemotherapy in 100 acute childhood leukemias

  1955cited by this paper
• Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists.

  1955cited by this paper
• Toxic nephrosis and massive hepatic necrosis produced by urethan.

  1955cited by this paper
• Fulminating hepatic necrosis in a patient with multiple myeloma treated with urethane; report of case.

  1955cited by this paper
• Studies on pathogenesis of amyloidosis. II. Effect of nitrogen mustard in inducing amyloidosis.

  1954cited by this paper
• Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route.

  1952cited by this paper
• A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.

  1950cited by this paper
• Urethane toxicity; report of a case of hepatic necrosis apparently due to urethane.

  1950cited by this paper
• The effects of nitrogen mustard on embryonic amphibian development; ectodermal effects.

  1947cited by this paper
• Inhibitory Effects of Ethyl Carbamate on Prostatic Cancer.

  1947cited by this paper

• Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration

  2011cites this paper
• 300 Surgery : The Effect of Immunosuppression on Cancer

  2010cites this paper
• Nutritional Consequences of Cancer Chemotherapy and Immunotherapy1

  2006cites this paper
• Immunosuppressive Therapie bei Pemphigus vulgaris

  2004cites this paper
• The effect of chemotherapy on the growing skeleton.

  2000cites this paper
• Fatal cyclophosphamide-induced interstitial pneumonitis in a renal transplant patient.

  1994cites this paper
• Immunosuppressive drug therapy in lupus nephritis.

  1993cites this paper
• Cyclophosphamide toxicity. Characterising and avoiding the problem.

  1991cites this paper
• Cyclophosphamide Toxicity

  1991cites this paper
• Wegener's granulomatosis.

  1989cites this paper
• Nutritional support of children with neoplastic diseases.

  1986cites this paper
• Drug-induced pulmonary disease. Part 1: Cytotoxic drugs.

  1986cites this paper
• Biochemical indices of cyclophosphamide-induced lung toxicity.

  1984cites this paper
• The pulmonary toxicity of antineoplastic agents.

  1982cites this paper
• Supportive nutritional intervention in pediatric cancer.

  1982cites this paper
• The effects of cancer and cancer therapy on male fertility.

  1981cites this paper
• 12. Antineoplastic Agents

  1981cites this paper
• Series on pharmacology in practice. 12. Antineoplastic agents.

  1981cites this paper
• Pulmonary fibrosis following low‐dose 1,3‐bis (2‐chloro‐ethyl)‐1‐nitrosourea (BCNU) therapy

  1980cites this paper
• Early-onset cyclophosphamide-induced interstitial pneumonitis.

  1979cites this paper
• The effects of azathioprine and 6 MP on immunity.

  1979cites this paper
• Cyclophosphamide pneumonitis.

  1978cites this paper
• A COMPARISON OF THE ANTIFERTILITY EFFECTS OF ALKYLATING AGENTS AND VINCA ALKALOIDS IN MALE RATS

  1978cites this paper
• Cytotoxic drug-induced lung disease.

  1977cites this paper
• Nutritional consequences of cancer chemotherapy and immunotherapy.

  1977cites this paper
• Pulmonary damage associated with sodium aurothiomalate therapy.

  1977cites this paper
• [Cytostatic pneumopathy following chemotherapy for metastasizing breast neoplasm].

  1977cites this paper
• METHOTREXATE-INDUCED PNEUMONITIS

  1976cites this paper
• Late side effects of treatment: skeletal, genetic, central nervous system, and oncogenic.

  1976cites this paper
• Cyclophosphamide therapy and interstitial pulmonary fibrosis

  1976cites this paper
• Non-oncogenic sequelae of cancer chemotherapy.

  1975cites this paper
• Immunosuppressive and cytotoxic chemotherapy: long-term complications.

  1975cites this paper
• Lung disease associated with methotrexate therapy.

  1974cites this paper
• Medical staff conference: Wegener's granulomatosis.

  1974cites this paper
• Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome.

  1974cites this paper
• Reversible drug-induced sterility in a patient with acute leukemia.

  1973cites this paper
• Acute leukemia complicating metastatic breast cancer

  1973cites this paper
• Fertility in patients treated for malignant testicular tumors.

  1973cites this paper
• Modulation of transfer RNA-methylating enzyme activities in murine leukemic cells.

  1972cites this paper
• Antitumor effects of the antispermatogenic agent, 2,3-dihydro-2-(1-naphthyl)-4(1H)-quinazolinone (NSC-145669).

  1972cites this paper
• Azathioprine in Ulcerative Colitis: An Interim Report on a Controlled Therapeutic Trial

  1972cites this paper
• Immunosuppressive therapy. 2.

  1972cites this paper
• Post-cyclophosphamide pneumonitis.

  1972cites this paper
• Immunosuppression--agents, procedures, speculations and prognosis.

  1972cites this paper
• [Side effects of immunosuppressive therapy].

  1972cites this paper
• Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis.

  1972cites this paper
• Proceedings: The effect of immunosuppression on cancer.

  1972cites this paper
• The Effect of Immunosuppression on Cancer

  1972cites this paper
• Immunologic Studies of the Fetal Allograft

  1971cites this paper
• Marrow transplanation in man following cyclophosphamide.

  1971cites this paper
• Alkylating agents and human spermatogenesis.

  1971cites this paper
• [Studies in rats on immunosuppressive properties of cytostatics with special consideration of carcinogenic effect].

  1970cites this paper
• Aseptic necrosis following renal transplantation.

  1969cites this paper
• [Immunosuppressive therapy of pemphigus vulgaris. Preliminary results of azathioprine (Imuran) treatment)].

  1969cites this paper
• The clinical use of immunosuppression.

  1969cites this paper
• Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice.

  1968cites this paper